Skip to main content
FinSpry Logo
FinSpry
TXG logo
TXG
(NASDAQ)
10x Genomics, Inc.
$63.80-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

10x Genomics (TXG) Stock Price & Financial Analysis

10x Genomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$60.93 - $64.38
52-Week High$60.69
52-Week Low$11.16
Open$63.15
Volume3.74M
Average Volume (3M)3.17M
Market Cap8.18B
Shares Outstanding128.29M
Price to Sales (P/S)11.65
Price to Book (P/B)9.14
EV/EBITDA75.36
Revenue (TTM)638.78M
Net Income (TTM)-22.66M
Free Cash Flow (TTM)122.18M
EPS (TTM)$-0.18
Profit Margin-3.55%
Operating Margin-6.06%
Return on Equity (ROE)-2.78%
Debt to Equity0.10
50-Day MA$42.72
200-Day MA$25.80
52-Week Change330.83%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About 10x Genomics

What is the current stock price for TXG?

As of the latest trading session, TXG stock trades at $63.80. The 52-week range is $11.16–$60.69, with a day range of $60.93–$64.38.

What is the P/E ratio for TXG?

The P/E ratio (Price-to-Earnings) for TXG is shown in the Key Statistics section. This valuation metric helps compare 10x Genomics, Inc. to industry peers.

Does TXG pay dividends?

10x Genomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TXG?

Based on 5 analysts, the consensus for TXG is Hold.

What is the market cap of TXG?

10x Genomics's market capitalization is $8.18B, classifying it as a mid-cap company. 10x Genomics operates in the Healthcare sector within the Health Information Services industry.